Search Results
The combined analysis of carfilzomib trials
FORTE study update: combined carfilzomib treatments in myeloma
Carfilzomib 2x Weekly in Combination with Dex and Daratumumab Vs Dara with Bortezomib and Dex
Daratumumab in combination with carfilzomib and dexamethasone for relapsed multiple myeloma
The Myeloma XI trial: adding carfilzomib to cyclophosphamide, lenalidomide, and dexamethasone
Phase III ASPIRE study of carfilzomib, lenalidomide and dexamethasone in relapsed myeloma
The FORTE clinical trial of carfilzomib in multiple myeloma
Iberdomide in combination with dexamethasone and daratumumab, bortezomib, or carfilzomib in RRMM...
Phase III study shows carfilzomib is an effective addition to standard myeloma therapy
Phase III study shows carfilzomib is an effective addition to standard myeloma therapy
Know Your Myeloma Therapy: Carfilzomib (Kyprolis) with Dr. Harsh Parmar
Primary Analysis Results from the Randomized, Open-Label, Phase 3 Study Candor
